Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Change in Accured Expenses: 2014-2024

Historic Change in Accured Expenses for Ocugen (OCGN) over the last 11 years, with Dec 2024 value amounting to $4.1 million.

  • Ocugen's Change in Accured Expenses rose 52.20% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 3819.63%. This contributed to the annual value of $4.1 million for FY2024, which is 133.52% up from last year.
  • Ocugen's Change in Accured Expenses amounted to $4.1 million in FY2024, which was up 133.52% from -$12.3 million recorded in FY2023.
  • In the past 5 years, Ocugen's Change in Accured Expenses ranged from a high of $9.5 million in FY2022 and a low of -$12.3 million during FY2023.
  • Over the past 3 years, Ocugen's median Change in Accured Expenses value was $4.1 million (recorded in 2024), while the average stood at $427,000.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 746.58% in 2021, then plummeted by 230.10% in 2023.
  • Over the past 5 years, Ocugen's Change in Accured Expenses (Yearly) stood at -$541,000 in 2020, then surged by 746.58% to $3.5 million in 2021, then soared by 171.21% to $9.5 million in 2022, then slumped by 230.10% to -$12.3 million in 2023, then surged by 133.52% to $4.1 million in 2024.